PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Alto Marketing Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

New Seward U.S Offices Achieve Sales Success - Seward sees 7500th Stomacher® 400 Circulator Paddle Blender sale
New Seward U.S Offices Achieve Sales Success

 

NewswireToday - /newswire/ - Southampton, Hampshire, United Kingdom, 2010/01/26 - Seward sees 7500th Stomacher® 400 Circulator Paddle Blender sale.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Seward Limited, manufacturer and developer of the world leading, patented Stomacher® Paddle Blender range for over 40 years, has recently achieved its 7500th global sale of its Stomacher® 400 Circulator. This success can be attributed to its growing US-based sales and technical support office, opened in Long Island, New York in September 2008, backed up by Seward’s global Headquarters in the UK, where all Stomacher blender systems are manufactured. Seward Laboratory Systems, Inc. (seward.co.uk) works closely with North American customers to deliver quality products and guarantee stock availability for food safety and life science sample preparation prior to microbiological analyses or PCR techniques.

Over 8 million food samples a day are now reproducibly homogenised using Stomacher® 400 paddle blender units and associated Stomacher® bags worldwide. Sample preparation is a critical step in all microbiological analyses and Stomacher paddle blenders guarantee reliable and consistent homogenising performance through industrial strength, power and build quality. Such is their quality, all Stomacher Lab Blenders hold a 3 year no quibble warranty.

The global success of the Stomacher® range of paddle blenders and bags is also demonstrated by the fact that Stomacher is the most highly referenced brand name in food safety and life science sample preparation. “We are extremely proud of the long history and excellent reputation of our Stomacher trademarked products, some of which are still in reliable routine use after 25 years,” said Stuart Ray, Technical Director, Seward Ltd. “The 7500th global sale of our Stomacher 400 Circulator system further highlights the world leading status of our Stomacher brand.”

Due to its unique patented paddle design the Stomacher® 400 Circulator blender enhances microorganism recovery over square paddle designed laboratory blenders. The stirring and extrusion forces applied to the sample by its patented design drive more organisms into suspension for analysis, making the Stomacher Circulator the gold standard in laboratory blenders. Used in conjunction with the Stomacher® Bag range, which fulfils all blending, straining and storage applications, the Circulator enables easy and effective processing of multiple samples without risk of cross contamination.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Alto Marketing Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


New Seward U.S Offices Achieve Sales Success

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Leigh Dilley - Alto-Marketing.com 
+44(0)14 8955 7672 sarahp[.]alto-marketing.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Alto Marketing Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Alto Marketing Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)